{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:36:45Z","timestamp":1792784205779,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Agnes Ginges Center for Human Neurogenetics"},{"name":"Granalix Biotechnologies"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.nbd.2017.08.012","type":"journal-article","created":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T23:02:43Z","timestamp":1503702163000},"page":"140-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Continues administration of Nano-PSO significantly increased survival of genetic CJD mice"],"prefix":"10.1016","volume":"108","author":[{"given":"Orli","family":"Binyamin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kati","family":"Frid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liraz","family":"Larush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomo","family":"Magdassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9306-2539","authenticated-orcid":false,"given":"Ruth","family":"Gabizon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2017.08.012_bb0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nature.2016.21045","article-title":"Failed Alzheimer's trial does not kill leading theory of disease","volume":"540","author":"Abbott","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2017.08.012_bb0010","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12906-017-1842-9","article-title":"Effect of pomegranate extracts on brain antioxidant markers and cholinesterase activity in high fat-high fructose diet induced obesity in rat model","volume":"17","author":"Amri","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.nbd.2017.08.012_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10545-013-9613-3","article-title":"Mucopolysaccharide diseases: a complex interplay between neuroinflammation, microglial activation and adaptive immunity","volume":"37","author":"Archer","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.nbd.2017.08.012_bb0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00966806","article-title":"Linoleic acid passage through the blood-brain barrier and a possible effect of age","volume":"19","author":"Avellini","year":"1994","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2017.08.012_bb0025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40478-017-0430-z","article-title":"Enhanced neuroinvasion by smaller, soluble prions","volume":"5","author":"Bett","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2017.08.012_bb0030","first-page":"7165","article-title":"Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant","volume":"10","author":"Binyamin","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.nbd.2017.08.012_bb0035","doi-asserted-by":"crossref","first-page":"64589","DOI":"10.18632\/oncotarget.10905","article-title":"Consumption of pomegranates improves synaptic function in a transgenic mice model of Alzheimer's disease","volume":"7","author":"Braidy","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.nbd.2017.08.012_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000977","article-title":"Oxidation of helix-3 methionines precedes the formation of PK resistant PrP","volume":"6","author":"Canello","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.nbd.2017.08.012_bb0045","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nature05294","article-title":"Prions and their partners in crime","volume":"443","author":"Caughey","year":"2006","journal-title":"Nature"},{"issue":"Pt 7","key":"10.1016\/j.nbd.2017.08.012_bb0050","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1099\/0022-1317-69-7-1753","article-title":"Replication of the scrapie agent in hamsters infected intracerebrally confirms the pathogenesis of an amyloid-inducing virosis","volume":"69","author":"Czub","year":"1988","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.nbd.2017.08.012_bb0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/B978-0-12-024911-4.50010-6","article-title":"Uptake and transport of fatty acids into the brain and the role of the blood-brain barrier system","volume":"11","author":"Dhopeshwarkar","year":"1973","journal-title":"Adv. Lipid Res."},{"key":"10.1016\/j.nbd.2017.08.012_bb0060","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0196-9781(02)00068-2","article-title":"Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases","volume":"23","author":"Diaz-Nido","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.nbd.2017.08.012_bb0065","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3389\/fnins.2016.00510","article-title":"Chronic progressive neurodegeneration in a transgenic mouse model of prion disease","volume":"10","author":"Fainstein","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2017.08.012_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002350","article-title":"Fatal prion disease in a mouse model of genetic E200K Creutzfeldt-Jakob disease","volume":"7","author":"Friedman-Levi","year":"2011","journal-title":"PLoS Pathog."},{"issue":"7","key":"10.1016\/j.nbd.2017.08.012_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069583","article-title":"PrPST, a soluble, protease resistant and truncated PrP form features in the pathogenesis of a genetic prion disease","volume":"8","author":"Friedman-Levi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2017.08.012_bb0080","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1073\/pnas.84.12.4017","article-title":"Purified prion proteins and scrapie infectivity copartition into liposomes","volume":"84","author":"Gabizon","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2017.08.012_bb0085","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1212\/WNL.0b013e3182a9f3b4","article-title":"Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease","volume":"81","author":"Geschwind","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2017.08.012_bb0090","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awx074","article-title":"Repurposed drugs targeting eIF2alpha-P-mediated translational repression prevent neurodegeneration in mice","author":"Halliday","year":"2017","journal-title":"Brain"},{"issue":"17","key":"10.1016\/j.nbd.2017.08.012_bb0095","doi-asserted-by":"crossref","first-page":"17057","DOI":"10.1074\/jbc.M411314200","article-title":"PrPSc incorporation to cells requires endogenous glycosaminoglycan expression","volume":"280","author":"Hijazi","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.nbd.2017.08.012_bb0100","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a023705","article-title":"Molecular genetics of neurodegenerative dementias","volume":"9","author":"Hinz","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.nbd.2017.08.012_bb0105","doi-asserted-by":"crossref","first-page":"26478","DOI":"10.1074\/jbc.M116.745851","article-title":"Heparan sulfate and heparin promote faithful prion replication in vitro by binding to normal and abnormal prion proteins in protein misfolding cyclic amplification","volume":"291","author":"Imamura","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2017.08.012_bb0110","doi-asserted-by":"crossref","first-page":"26164","DOI":"10.1074\/jbc.M116.745612","article-title":"Identification of anti-prion compounds using a novel cellular assay","volume":"291","author":"Imberdis","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2017.08.012_bb0115","first-page":"128","article-title":"Therapeutic applications of pomegranate (Punica granatum L.): a review","volume":"13","author":"Jurenka","year":"2008","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.nbd.2017.08.012_bb0120","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1161\/01.ATV.21.3.386","article-title":"Retention of oxidized LDL by extracellular matrix proteoglycans leads to its uptake by macrophages: an alternative approach to study lipoproteins cellular uptake","volume":"21","author":"Kaplan","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.nbd.2017.08.012_bb0125","doi-asserted-by":"crossref","first-page":"7044","DOI":"10.1073\/pnas.1303510110","article-title":"Unique drug screening approach for prion diseases identifies tacrolimus and astemizole as antiprion agents","volume":"110","author":"Karapetyan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2017.08.012_bb0130","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1128\/JVI.80.2.1044-1046.2006","article-title":"Mefloquine, an antimalaria drug with antiprion activity in vitro, lacks activity in vivo","volume":"80","author":"Kocisko","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.nbd.2017.08.012_bb0135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0076-6879(06)12014-5","article-title":"Searching for anti-prion compounds: cell-based high-throughput in vitro assays and animal testing strategies","volume":"412","author":"Kocisko","year":"2006","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.nbd.2017.08.012_bb0140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00401-010-0713-y","article-title":"Genetic Creutzfeldt-Jakob disease associated with the E200K mutation: characterization of a complex proteinopathy","volume":"121","author":"Kovacs","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2017.08.012_bb0145","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1126\/science.275.5298.402","article-title":"Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein","volume":"275","author":"Lasmezas","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nbd.2017.08.012_bb0150","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/brain\/awt062","article-title":"Brain amyloid-beta oligomers in ageing and Alzheimer's disease","volume":"136","author":"Lesne","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2017.08.012_bb0155","first-page":"550","article-title":"The neuroprotective effects of resveratrol preconditioning in transient global cerebral ischemia-reperfusion in mice","volume":"26","author":"Liu","year":"2015","journal-title":"Turk. Neurosurg."},{"key":"10.1016\/j.nbd.2017.08.012_bb0160","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1203\/01.PDR.0000157722.07810.15","article-title":"Maternal dietary supplementation with pomegranate juice is neuroprotective in an animal model of neonatal hypoxic-ischemic brain injury","volume":"57","author":"Loren","year":"2005","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.nbd.2017.08.012_bb0165","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1073\/pnas.2627988100","article-title":"Potent inhibition of scrapie prion replication in cultured cells by bis-acridines","volume":"100","author":"May","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2017.08.012_bb0170","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.nbd.2005.05.009","article-title":"The metabolism of glycosaminoglycans is impaired in prion diseases","volume":"20","author":"Mayer-Sonnenfeld","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2017.08.012_bb0175","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s10571-008-9274-1","article-title":"Chemically induced accumulation of GAGs delays PrP(Sc) clearance but prolongs prion disease incubation time","volume":"28","author":"Mayer-Sonnenfeld","year":"2008","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2017.08.012_bb0180","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.nano.2014.03.015","article-title":"Pomegranate seed oil nanoemulsions for the prevention and treatment of neurodegenerative diseases: the case of genetic CJD","volume":"10","author":"Mizrahi","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nbd.2017.08.012_bb0185","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1080\/13880209.2016.1199039","article-title":"Pomegranate seed oil nanoemulsions with selective antiglioma activity: optimization and evaluation of cytotoxicity, genotoxicity and oxidative effects on mononuclear cells","volume":"54","author":"Mota Ferreira","year":"2016","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.nbd.2017.08.012_bb0190","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1172\/JCI118853","article-title":"Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma","volume":"98","author":"Palinski","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2017.08.012_bb0195","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2174\/138920311795860188","article-title":"Glycosaminoglycans, protein aggregation and neurodegeneration","volume":"12","author":"Papy-Garcia","year":"2011","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.nbd.2017.08.012_bb0200","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35089090","article-title":"Antibodies inhibit prion propagation and clear cell cultures of prion infectivity","volume":"412","author":"Peretz","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2017.08.012_bb0205","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1146\/annurev-genet-110711-155524","article-title":"Biology and genetics of prions causing neurodegeneration","volume":"47","author":"Prusiner","year":"2013","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.nbd.2017.08.012_bb0210","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/JVI.80.2.596-604.2006","article-title":"Inhibition of protease-resistant prion protein formation in a transformed deer cell line infected with chronic wasting disease","volume":"80","author":"Raymond","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.nbd.2017.08.012_bb0215","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3109\/09687688.2010.516276","article-title":"Multifunctionality of lipid-core micelles for drug delivery and tumour targeting","volume":"27","author":"Sawant","year":"2010","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.nbd.2017.08.012_bb0220","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbrc.2003.10.150","article-title":"Novel heparan mimetics potently inhibit the scrapie prion protein and its endocytosis","volume":"312","author":"Schonberger","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2017.08.012_bb0225","doi-asserted-by":"crossref","first-page":"14324","DOI":"10.1074\/jbc.M007815200","article-title":"Reconstitution of prion infectivity from solubilized protease-resistant PrP and nonprotein components of prion rods","volume":"276","author":"Shaked","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2017.08.012_bb0230","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neuroscience.2016.02.055","article-title":"Quercetin attenuates neuronal death against aluminum-induced neurodegeneration in the rat hippocampus","volume":"324","author":"Sharma","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2017.08.012_bb0235","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.bmc.2014.01.001","article-title":"Novel compounds lowering the cellular isoform of the human prion protein in cultured human cells","volume":"22","author":"Silber","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.nbd.2017.08.012_bb0240","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nature03989","article-title":"The most infectious prion protein particles","volume":"437","author":"Silveira","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2017.08.012_bb0245","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00687367","article-title":"Sulfated glycosaminoglycans in amyloid plaques of prion diseases","volume":"77","author":"Snow","year":"1989","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2017.08.012_bb0250","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1471-4159.1988.tb02958.x","article-title":"Fatty acid transport through the blood-brain barrier","volume":"50","author":"Spector","year":"1988","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2017.08.012_bb0255","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4103\/2225-4110.139107","article-title":"Pomegranate from Oman alleviates the brain oxidative damage in transgenic mouse model of Alzheimer's disease","volume":"4","author":"Subash","year":"2014","journal-title":"J. Tradit. Complement. Med."},{"key":"10.1016\/j.nbd.2017.08.012_bb0260","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/00005072-199706000-00007","article-title":"Mice deficient in all forms of lysosomal beta-hexosaminidase show mucopolysaccharidosis-like pathology","volume":"56","author":"Suzuki","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2017.08.012_bb0265","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ymgme.2013.06.007","article-title":"Newborn screening and diagnosis of mucopolysaccharidoses","volume":"110","author":"Tomatsu","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.nbd.2017.08.012_bb0270","doi-asserted-by":"crossref","first-page":"3279061","DOI":"10.1155\/2017\/3279061","article-title":"Protective effect of antioxidants on neuronal dysfunction and plasticity in Huntington's disease","volume":"2017","author":"Velusamy","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.nbd.2017.08.012_bb0275","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1096\/fj.13-246777","article-title":"Heparin binding confers prion stability and impairs its aggregation","volume":"28","author":"Vieira","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2017.08.012_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006491","article-title":"Self-propagating, protease-resistant, recombinant prion protein conformers with or without in vivo pathogenicity","volume":"13","author":"Wang","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.nbd.2017.08.012_bb0285","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/emboj\/20.3.377","article-title":"Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein","volume":"20","author":"Wong","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2017.08.012_bb0290","first-page":"1563","article-title":"Visual pathology in animal prion diseases","volume":"24","author":"Ye","year":"2009","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.nbd.2017.08.012_bb0295","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.1073\/pnas.0610827104","article-title":"Human prion proteins with pathogenic mutations share common conformational changes resulting in enhanced binding to glycosaminoglycans","volume":"104","author":"Yin","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2017.08.012_bb0300","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/brain\/awv002","article-title":"Neuronal death induced by misfolded prion protein is due to NAD+ depletion and can be relieved in vitro and in vivo by NAD+ replenishment","volume":"138","author":"Zhou","year":"2015","journal-title":"Brain"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996117301924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996117301924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T10:49:32Z","timestamp":1549795772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996117301924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":60,"alternative-id":["S0969996117301924"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2017.08.012","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continues administration of Nano-PSO significantly increased survival of genetic CJD mice","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2017.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}